
55.87 Delayed Data As of May 25 | ![]() Today’s Change | 46.93 Today|||52-Week Range 58.10 | +11.52% Year-to-Date |
Biotech Stock Roundup: ETTX Up on Acquisition Deal, REGN Offers Updates May 25 / Zacks.com - Paid Partner Content | Sanofi, Regeneron's Dupixent Gets FDA Nod for 4th Indication May 23 / Zacks.com - Paid Partner Content |
Sanofi, Regeneron's Dupixent Gets FDA Nod for 4th Indication (Revised) May 25 / Zacks.com - Paid Partner Content | This Safe Stock Is Dirt Cheap -- and It's Beating the Market May 20 / MotleyFool.com - Paid Partner Content |
The Zacks Analyst Blog Highlights Alphabet, UnitedHealth Group, Costco Wholesale, Cisco Systems and Sanofi May 24 / Zacks.com - Paid Partner Content | Regulus (RGLS) Up as FDA Accepts IND for Kidney Disease Drug May 12 / Zacks.com - Paid Partner Content |
Top Stock Reports for Alphabet, UnitedHealth & Costco May 23 / Zacks.com - Paid Partner Content |
Previous close | 56.29 |
Today’s open | 55.74 |
Day’s range | 55.55 - 55.94 |
Volume | 88,121 |
Average volume (3 months) | 2,148,639 |
Market cap | $136.2B |
Earnings growth (last year) | -47.56% |
Earnings growth (this year) | -96.15% |
Earnings growth (next 5 years) | +8.75% |
Revenue growth (last year) | +8.63% |
P/E ratio | 21.1 |
Price/Sales | 2.82 |
Price/Book | 1.74 |
Today’s change | Today’s % change | |
---|---|---|
BMYBristol-Myers Squibb | +0.12 | +0.16% |
GSKGlaxoSmithKline | -0.01 | -0.02% |
NVONovo Nordisk | -2.73 | -2.53% |
NVSNovartis | -0.66 | -0.72% |
Last reporting date | -- |
EPS forecast (this quarter) | $0.70 |
Annual revenue (last year) | $44.6B |
Annual profit (last year) | $7.4B |
Net profit margin | 16.48% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Paris, Ile-de-france |